These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate. de Sandro V, Catinot R, Kriszt W, Cordier A, Richert L. Biochem Pharmacol; 1992 Apr 01; 43(7):1563-9. PubMed ID: 1567478 [Abstract] [Full Text] [Related]
11. Evidence of chemical stimulation of hepatic metabolism by an experimental acetanilide (FOE 5043) indirectly mediating reductions in circulating thyroid hormone levels in the male rat. Christenson WR, Becker BD, Wahle BS, Moore KD, Dass PD, Lake SG, Van Goethem DL, Stuart BP, Sangha GK, Thyssen JH. Fundam Appl Toxicol; 1996 Feb 01; 29(2):251-9. PubMed ID: 8742323 [Abstract] [Full Text] [Related]
16. Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat. Smith PF, Grossman SJ, Gerson RJ, Gordon LR, Deluca JG, Majka JA, Wang RW, Germershausen JI, MacDonald JS. Toxicol Pathol; 1991 Jan 01; 19(3):197-205. PubMed ID: 1780636 [Abstract] [Full Text] [Related]
19. Phenobarbital, beta-naphthoflavone, clofibrate, and pregnenolone-16alpha-carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice. Viollon-Abadie C, Lassere D, Debruyne E, Nicod L, Carmichael N, Richert L. Toxicol Appl Pharmacol; 1999 Feb 15; 155(1):1-12. PubMed ID: 10036213 [Abstract] [Full Text] [Related]